Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.54 |
| ▸ | HTR7 | P34969 | 7/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | DHODH | Q02127 | 2/20 | 0.44 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | DRD4 | P21917 | 2/20 | 0.43 |
| ▸ | DRD3 | P35462 | 2/20 | 0.43 |
| ▸ | DRD1 | P21728 | 2/20 | 0.43 |
| ▸ | DRD5 | P21918 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.41 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2002333 | 0.87 | CYP2A13 (0.50) | HRH3HTR7ALDH1A1DHODHADORA2A | |
| SCHEMBL1540038 | 0.83 | HTR7 (0.71) | HTR7ALDH1A1DRD2DRD4DRD3 | |
| SCHEMBL7184871 | 0.82 | TRPV1 (0.48) | HTR7 | |
| SCHEMBL1540315 | 0.82 | HTR7 (0.74) | HTR7ALDH1A1DRD2DRD4DRD3 | |
| SCHEMBL13681861 | 0.81 | TRPV1 (0.50) | HTR7 | |
| SCHEMBL1540289 | 0.81 | BCL2 (0.60) | HTR7ALDH1A1DRD2DRD4DRD3 | |
| SCHEMBL1540394 | 0.81 | HTR7 (0.60) | HTR7ALDH1A1 | |
| SCHEMBL1540016 | 0.79 | MEN1 (0.51) | HTR7DRD2DRD4DRD3BACE1 | |
| SCHEMBL1997164 | 0.79 | DRD1 (0.51) | ALDH1A1DRD2DRD4DRD3DRD1 | |
| SCHEMBL1539994 | 0.78 | HTR7 (0.57) | HTR7ALDH1A1DRD2DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1311499-A2 | BICYCLIC COMPOUNDS AS H3 RECEPTOR LIGANDS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002012224-A2 | BICYCLIC COMPOUNDS AS H3 RECEPTOR LIGANDS | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2002-02-14 | — | — | WO | disclosed |